Bawand Rashed, Ghiasian Masoud, Samadyan Mustapha, Qaderi Sorush
Department of General Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Department of Neuroimmunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Helicobacter. 2023 Oct;28(5):e13010. doi: 10.1111/hel.13010. Epub 2023 Aug 2.
BACKGROUND: Migraine is one of the most common neurological disorders that can severely overshadow people's quality of life, and Helicobacter pylori infection is a health problem in different societies. During the last two decades, many original studies have been conducted on the various aspects of the relationship between these two disorders; however, they have reported different and sometimes contradictory results. METHODS: This study was conducted based on the PRISMA protocol. We performed a comprehensive literature search in the online databases up to May 2023, and 22 studies that contained original data on the relationship between H. pylori infection and migraine headaches in adults were included. For performing the meta-analysis, we calculated the odds ratios (OR) and 95% confidence intervals (CI), using a random-effects model, and to determine the possible causes of heterogeneity, we conducted a subgroup meta-analysis. RESULTS: The overall OR for the association of H. pylori infection and migraine headaches through 493,794 evaluated individuals was 2.80 [95% CI = 1.75-4.48; I = 89.20, p < 0.01], which reveals a statistically significant association between these disorders. It was found that the studies that were conducted in Asian regions and the recently published ones have clearly shown a higher association between migraine and H. pylori infection. On the other hand, migraine patients who are infected with H. pylori have similar signs and symptoms as H. pylori-negative migraineurs; meanwhile, the clinical trials conducted in this field strongly emphasize the benefits of eradicating H. pylori infection in migraine patients and have estimated its effectiveness in improving migraine headaches equivalent to current common migraine treatments. Furthermore, it was reported that white matter lesions were 2.5-fold higher on brain MRI in patients with H. pylori-positive migraine compared with H. pylori-negative migraineurs; however, the evidence does not support the role of oxidative stress in patients suffering from H. pylori infection and migraine and refuses the role of Cag-A-positive strains of H. pylori in migraine headaches. CONCLUSION: According to the currently available data, it seem reasonable that patients with a definite diagnosis of migraine who also suffer from gastrointestinal problems, undergo the H. pylori detection tests and if the evaluations are positive, H. pylori eradication treatment can be considered even before any migraine treatment.
背景:偏头痛是最常见的神经系统疾病之一,严重影响人们的生活质量,而幽门螺杆菌感染是不同社会群体面临的健康问题。在过去二十年中,针对这两种疾病之间关系的各个方面进行了许多原创性研究;然而,这些研究报告的结果各不相同,有时甚至相互矛盾。 方法:本研究基于PRISMA协议进行。我们在截至2023年5月的在线数据库中进行了全面的文献检索,纳入了22项包含成人幽门螺杆菌感染与偏头痛关系原始数据的研究。为进行荟萃分析,我们使用随机效应模型计算比值比(OR)和95%置信区间(CI),并进行亚组荟萃分析以确定异质性的可能原因。 结果:通过对493,794名个体的评估,幽门螺杆菌感染与偏头痛之间关联的总体OR为2.80 [95% CI = 1.75 - 4.48;I² = 89.20,p < 0.01],这表明这两种疾病之间存在统计学上的显著关联。研究发现,在亚洲地区进行的研究以及最近发表的研究清楚地表明偏头痛与幽门螺杆菌感染之间的关联更高。另一方面,感染幽门螺杆菌的偏头痛患者与未感染幽门螺杆菌的偏头痛患者具有相似的体征和症状;同时,该领域进行的临床试验强烈强调根除偏头痛患者幽门螺杆菌感染的益处,并估计其在改善偏头痛方面的有效性与目前常见的偏头痛治疗相当。此外,据报道,幽门螺杆菌阳性偏头痛患者脑MRI上的白质病变比幽门螺杆菌阴性偏头痛患者高2.5倍;然而,证据不支持氧化应激在幽门螺杆菌感染和偏头痛患者中的作用,也否定了幽门螺杆菌Cag-A阳性菌株在偏头痛中的作用。 结论:根据目前可得的数据,对于确诊偏头痛且伴有胃肠道问题的患者,进行幽门螺杆菌检测似乎是合理的,如果评估结果为阳性,甚至可以在进行任何偏头痛治疗之前考虑根除幽门螺杆菌治疗。
Cochrane Database Syst Rev. 2016-6-28
Cochrane Database Syst Rev. 2018-3-15
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-10-19
Cochrane Database Syst Rev. 2017-12-22
Health Technol Assess. 2024-10
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2022-5-20
Acta Neurol Belg. 2025-4-3
Biomolecules. 2024-12-28
Mol Neurobiol. 2025-5